P10 (PX) Reports Q1 Earnings: What Key Metrics Have to Say

By Zacks Equity Research | May 08, 2025, 9:30 AM

For the quarter ended March 2025, P10, Inc. (PX) reported revenue of $67.67 million, up 2.3% over the same period last year. EPS came in at $0.20, compared to $0.21 in the year-ago quarter.

The reported revenue represents a surprise of -1.65% over the Zacks Consensus Estimate of $68.8 million. With the consensus EPS estimate being $0.21, the EPS surprise was -4.76%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how P10 performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • FPAUM(Fee Paying Assets Under Management) - Period Ending: $26.30 billion compared to the $26.11 billion average estimate based on three analysts.
  • Revenues- Management and advisory fees: $66.74 million versus the three-analyst average estimate of $67.36 million. The reported number represents a year-over-year change of +2.5%.
  • Revenues- Other revenue: $0.93 million compared to the $1.44 million average estimate based on three analysts. The reported number represents a change of -6.1% year over year.
View all Key Company Metrics for P10 here>>>

Shares of P10 have returned +7.6% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
P10, Inc. (PX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News